Yu Du

1.8k total citations
73 papers, 1.4k citations indexed

About

Yu Du is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Yu Du has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 16 papers in Surgery and 13 papers in Pharmacology. Recurrent topics in Yu Du's work include Microbial Natural Products and Biosynthesis (7 papers), Connexins and lens biology (6 papers) and Cholesterol and Lipid Metabolism (6 papers). Yu Du is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Connexins and lens biology (6 papers) and Cholesterol and Lipid Metabolism (6 papers). Yu Du collaborates with scholars based in China, United States and Hong Kong. Yu Du's co-authors include Bin Hong, Li Wang, Chunyan Su, Shuyi Si, Xinran Gao, Jin‐Fang Ge, Lei Peng, Xiaojian Jia, Fan Yang and Zhibo Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Energy & Environmental Science and Journal of the American College of Cardiology.

In The Last Decade

Yu Du

71 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Du China 18 827 236 212 187 162 73 1.4k
Xin Jin China 25 754 0.9× 319 1.4× 114 0.5× 138 0.7× 229 1.4× 69 2.0k
Jisun Oh South Korea 28 958 1.2× 135 0.6× 177 0.8× 160 0.9× 169 1.0× 86 2.0k
Jiye Aa China 26 1.1k 1.3× 196 0.8× 300 1.4× 96 0.5× 188 1.2× 54 1.8k
Clinton D. Allred United States 27 912 1.1× 251 1.1× 224 1.1× 151 0.8× 156 1.0× 57 2.7k
Lin Luo China 16 1.1k 1.4× 168 0.7× 129 0.6× 128 0.7× 139 0.9× 32 2.1k
Kee-Ching Jeng Taiwan 26 696 0.8× 268 1.1× 99 0.5× 163 0.9× 238 1.5× 60 2.1k
Chunhua Ma China 28 1.2k 1.4× 249 1.1× 249 1.2× 158 0.8× 264 1.6× 56 2.3k
Dapeng Chen China 24 1.0k 1.3× 123 0.5× 230 1.1× 175 0.9× 120 0.7× 67 2.0k
Syed Minhaj Uddin Ahmed Bangladesh 4 833 1.0× 141 0.6× 89 0.4× 101 0.5× 97 0.6× 10 1.5k
Fügen Aktan Türkiye 16 717 0.9× 360 1.5× 131 0.6× 122 0.7× 166 1.0× 27 2.0k

Countries citing papers authored by Yu Du

Since Specialization
Citations

This map shows the geographic impact of Yu Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Du more than expected).

Fields of papers citing papers by Yu Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Du. The network helps show where Yu Du may publish in the future.

Co-authorship network of co-authors of Yu Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Du. A scholar is included among the top collaborators of Yu Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Du. Yu Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Pengcheng, Tianhao Liu, Meihui Jiang, et al.. (2025). Enhancing green mobility through vehicle-to-grid technology: potential, technological barriers, and policy implications. Energy & Environmental Science. 18(10). 4496–4520. 6 indexed citations
2.
Du, Yu, Yong Wang, Zhenglin Wang, et al.. (2024). Stigmast-4-en-3-one from Euonymus alatus (Thunb.) Siebold. improves diabetic retinopathy and angiogenesis mediated by glucocorticoids receptor. Journal of Ethnopharmacology. 334. 118567–118567. 3 indexed citations
3.
Du, Yu, et al.. (2024). Construction of a mortality risk prediction model for patients with acute diquat poisoning based on clinically accessible data. Journal of Occupational Medicine and Toxicology. 19(1). 20–20. 1 indexed citations
4.
Wang, Guangyan, Manuel A. Riquelme, Yu Du, et al.. (2024). Mechano-activated connexin hemichannels and glutathione transport protect lens fiber cells against oxidative insults. Redox Biology. 73. 103216–103216. 2 indexed citations
5.
Li, Yihong, Yu Du, Weicong Ren, et al.. (2023). Genome-Directed Discovery of Bicyclic Cinnamoyl-Containing Nonribosomal Peptides with Anticoronaviral Activity from Streptomyces griseus. Organic Letters. 25(26). 4874–4879. 7 indexed citations
6.
Du, Yu, et al.. (2023). Protein kinase A activation alleviates cataract formation via increased gap junction intercellular communication. iScience. 26(3). 106114–106114. 6 indexed citations
7.
Zhang, Jin, Xuelei Wang, Fan Yang, et al.. (2022). MicroRNA-185 modulates CYP7A1 mediated cholesterol-bile acid metabolism through post-transcriptional and post-translational regulation of FoxO1. Atherosclerosis. 348. 56–67. 12 indexed citations
8.
Du, Yu, Ruifang Zheng, Xiumin Zhang, et al.. (2022). Tilianin improves lipid profile and alleviates atherosclerosis in ApoE−/− mice through up-regulation of SREBP2-mediated LDLR expression. Phytomedicine. 109. 154577–154577. 13 indexed citations
9.
Li, Xingxing, Chunyan Su, Zhibo Jiang, et al.. (2021). Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. npj Biofilms and Microbiomes. 7(1). 36–36. 113 indexed citations
10.
Wang, Wenqi, Xin Feng, Yu Du, et al.. (2021). Synthesis of Novel Pinocembrin Amino Acid Derivatives and Their Antiaging Effect on Caenorhabditis elegans via the Modulating DAF-16/FOXO. Drug Design Development and Therapy. Volume 15. 4177–4193. 10 indexed citations
11.
12.
Li, Xingxing, Shuo Wu, Yu Du, et al.. (2020). Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model. International Journal of Antimicrobial Agents. 56(1). 106000–106000. 28 indexed citations
13.
Wang, Xuelei, Xiaofang Chen, Xiumin Zhang, et al.. (2020). A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α. EBioMedicine. 52. 102650–102650. 38 indexed citations
14.
Yang, Fan, Yu Du, Jin Zhang, et al.. (2016). Low-density lipoprotein upregulate SR-BI through Sp1 Ser702 phosphorylation in hepatic cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(9). 1066–1075. 11 indexed citations
15.
Li, Xiaoyan, et al.. (2016). GW27-e0287 Salvianolic Acid B Reduces Low-density Lipoprotein Cholesterol and Inhibits Inflammation in Apolipoprotein E-deficient Mice. Journal of the American College of Cardiology. 68(16). C46–C47. 1 indexed citations
16.
Zhang, Jin, Yu Du, Xiaojian Jia, et al.. (2015). microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Atherosclerosis. 243(2). 523–532. 59 indexed citations
17.
Li, SH, et al.. (2013). Excision of a selectable marker in transgenic lily (Sorbonne) using the Cre/loxP DNA excision system. BioOne Complete (BioOne). 2 indexed citations
18.
Tang, Yuying, Yu Du, Juan Ni, et al.. (2013). Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study. International Journal of Obstetric Anesthesia. 23(2). 131–137. 12 indexed citations
19.
Zhu, Yuanjun, Lifei Wang, Yu Du, et al.. (2010). Heterologous expression of human interleukin-6 in Streptomyces lividans TK24 using novel secretory expression vectors. Biotechnology Letters. 33(2). 253–261. 11 indexed citations
20.
Mak, Duncan H., et al.. (2004). A yang‐promoting Chinese herbal suppository preparation enhances the antioxidant status of red cells in male human subjects. Phytotherapy Research. 18(7). 525–530. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026